Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus.
CAT No: 10-101-59
CAS No:204656-20-2
Synonyms/Alias:Liraglutide;204656-20-2;NN2211;victoza;Liraglutida;NN-2211;Liraglutidum;NN 2211;Liraglutidum [INN-Latin];Liraglutida [INN-Spanish];NNC 90-1170;UNII-839I73S42A;HSDB 8205;Liraglutide (rDNA origin);NNC-90-1170;CHEMBL4084119;Saxenda;CHEBI:71193;DTXSID60174433;839I73S42A;NN-9924;N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)GLP-1-(7-37)-peptide;Liraglutidum (INN-Latin);Liraglutida (INN-Spanish);N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glucagon-like-peptide-1-(7-37)-peptide;Arg34Lys26-(N-epsilon-(gamma-Glu(N-alpha-hexadecanoyl)))-GLP-1(7-37);N(sup 26)-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)GLP-1-(7-37)-peptide;Liraglutide recombinant;Liraglutide?;L-Histidyl-L-alanyl-L-a-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-a-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-a-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-N6-[N-(1-oxohexadecyl)-L-?-glutamyl]-L-lysyl-L-a-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-arginylglycyl-L-arginylglycine;Liraglutide [USAN:INN:BAN:JAN];Liraglutidum (Latin);LIRAGLUTIDE (MART.);GTPL1133;DTXCID6096924;A10BJ02;EX-A2418;BDBM50240819;NN9924;AKOS037435224;AS-56276;DA-65005;FL109949;XULTOPHY 100/3.6 COMPONENT LIRAGLUTIDE;LIRAGLUTIDE COMPONENT OF XULTOPHY 100/3.6;NN2211; (Lys(?-Glu-palmitoyl)(2)?,Arg(3)?)-GLP-1 (7-37);ARG(SUP 34)LYS(SUP 26)-(N-epsilon-(gamma-GLU(N-alpha-HEXADECANOYL)))-GLP-1(7-37);N(SUP epsilon26)-(N-HEXADECANOYL-L-gamma-GLUTAMYL)-(34-L-ARGININE)GLUCAGON-LIKE PEPTIDE 1-(7-37)-PEPTIDE;N26-(N-Hexadecanoyl-L-gamma-glutamyl)-(34-L-arginine)glucagon-like peptide 1-(7-37)-peptide;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.